Respiratory diseases pose increasing challenges to healthcare in Vietnam
Experts say respiratory diseases pose significant challenges to Vietnam’s healthcare system (photo: T. Duong) At a June 8 conference on...
Lung Healthcare
Lung Cancer Drugs Shows Promise for Treatment-Resistant Melanoma
A class of targeted therapies currently used to treat lung and other cancers may be effective for patients with a...
Early Action Could Save Thousands
Breakthrough Lung Cancer Screening Technology Offers Hope for Early Intervention Low-dose computed tomography (LDCT) scans are...
Wildfire Smoke Dents Survival Odds For Lung Cancer Patients | Health
Key TakeawaysWildfire smoke decreases lung cancer patients’ odds of survivalCalifornians with lung cancer had a 20% increased risk of deathAdvanced...
National variation in the treatment of lung cancer in a universal healthcare context
Over our study period, the most common treatment received by those with lung cancer in Aotearoa New Zealand was radiation...
MHRA approves aumolertinib to treat non-small cell lung cancer
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 3 June 2025, approved aumolertinib (Aumseqa) for adult patients with...
Lung cancer blood test to be rolled out across NHS
A blood test that can detect lung cancer is being rolled out across the NHS to speed up access to...
Wildfire Smoke Dents Survival Odds For Lung Cancer Patients | Health
Key TakeawaysWildfire smoke decreases lung cancer patients’ odds of survivalCalifornians with lung cancer had a 20% increased risk of deathAdvanced...
Bayer’s sevabertinib gets priority review for treatment of non-small cell lung cancer
Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) and granted...
